Peningkatan Kesadaran Masyarakat Tentang Infeksi Tuberkulosis Paru Pasca Covid-19
Keywords:
Covid-19, Peningkatan Kesadaran Masyarakat, Tuberkulosis ParuAbstract
Pulmonary tuberculosis, often called TB, is a bacterial infection caused by Mycobacterium tuberculosis. Indonesia is one of eight countries that accounts for 2/3 of TB cases worldwide. This disease usually affects the lungs, but can also attack other organs in the body. TB symptoms can vary depending on the type of infection and the organs affected. During the COVID-19 pandemic, attention to other diseases, such as TB has decreased. The increasing risk of spreading TB after COVID-19 is a public health concern. Restrictions on social movement implemented during the COVID-19 pandemic may result in an increased risk of TB transmission among close contacts of TB sufferers. People who have had COVID-19, especially those who have had lung damage due to COVID-19 infection, may have a higher risk of developing TB due to a weakened immune system. This Community Service is carried out to increase public awareness of the dangers of TB that continue to lurk after COVID-19 and it is hoped that through this outreach and education, the public will become more aware of the symptoms of TB so they can check themselves at Primary Health Care.
References
Alene, K. A., Wangdi, K., & Clements, A. C. (2020). Impact of the COVID-19 pandemic on tuberculosis control: an overview. Tropical Medicine and Infectious Disease, 5(3), 123. https://doi.org/10.3390/tropicalmed5030123
Chakaya, J., Khan, M., Ntoumi, F., Aklillu, E., Fatima, R., Mwaba, P., Kapata, N., Mfinanga, S., Hasnain, S. E., & Katoto, P. D. (2021). Global Tuberculosis Report 2020–Reflections on the Global TB burden, treatment and prevention efforts. International Journal of Infectious Diseases, 113, S7-S12. https://doi.org/10.1016/j.ijid.2021.02.107
Damaranti, C. P., & Hidayat, B. (2023). Tantangan dan Strategi Manajemen Pasien Tuberculosis di Negara Berkembang Selama Masa Pandemi COVID-19: Literature Review. Media Publikasi Promosi Kesehatan Indonesia (MPPKI), 6(3), 393-403. https://doi.org/10.56338/mppki.v6i3.2995
Li, C., Ni, Y.-Q., Xu, H., Xiang, Q.-Y., Zhao, Y., Zhan, J.-K., He, J.-Y., Li, S., & Liu, Y.-S. (2021). Roles and mechanisms of exosomal non-coding RNAs in human health and diseases. Signal Transduction And Targeted Therapy, 6(1), 383. https://doi.org/10.1038/s41392-021-00779-x
Loddenkemper, R., & Murray, J. F. (2021). History of tuberculosis. Essential Tuberculosis, 3-9. https://doi.org/10.1007/978-3-030-66703-0_1
Menzies, N. A., Quaife, M., Allwood, B. W., Byrne, A. L., Coussens, A. K., Harries, A. D., Marx, F. M., Meghji, J., Pedrazzoli, D., & Salomon, J. A. (2021). Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae. The Lancet Global Health, 9(12), e1679-e1687. https://doi.org/10.1016/S2214-109X(21)00367-3
Migliori, G. B., Thong, P. M., Alffenaar, J.-W., Denholm, J., Tadolini, M., Alyaquobi, F., Blanc, F.-X., Buonsenso, D., Cho, J.-G., & Codecasa, L. R. (2021). Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study. European Respiratory Journal, 58(5). https://doi.org/10.1183/13993003.01786-2021
Tripathy, S., Srivastava, K., Kant, S., & Sarin, R. (2018). History of Tuberculosis. National Medicos Organisation Journal (एन एम ओ जर्नल)(ISSN-2348-3806), 12(01), 14-18.
Visca, D., Ong, C., Tiberi, S., Centis, R., D’ambrosio, L., Chen, B., Mueller, J., Mueller, P., Duarte, R., & Dalcolmo, M. (2021). Tuberculosis and COVID-19 interaction: a review of biological, clinical and public health effects. Pulmonology, 27(2), 151-165. https://doi.org/10.1016/j.pulmoe.2020.12.012
